| id | C00000911 |
|---|---|
| Name | Lycopene / all-trans-Lycopene |
| CAS RN | 502-65-8 |
| Standard InChI | InChI=1S/C40H56/c1-33(2)19-13-23-37(7)27-17-31-39(9)29-15-25-35(5)21-11-12-22-36(6)26-16-30-40(10)32-18-28-38(8)24-14-20-34(3)4/h11-12,15-22,25-32H,13-14,23-24H2,1-10H3/b12-11+,25-15+,26-16+,31-17+,32-18+,35-21+,36-22+,37-27+,38-28+,39-29+,40-30+ |
| Standard InChI (Main Layer) | InChI=1S/C40H56/c1-33(2)19-13-23-37(7)27-17-31-39(9)29-15-25-35(5)21-11-12-22-36(6)26-16-30-40(10)32-18-28-38(8)24-14-20-34(3)4/h11-12,15-22,25-32H,13-14,23-24H2,1-10H3 |
| Phytochemical cluster | No. 59 |
|---|---|
| KCF-S cluster | No. 97 |
| By standard InChI | CHEMBL501174 |
|---|---|
| By standard InChI Main Layer | CHEMBL501174 CHEMBL1984187 |
| By LinkDB | C05432 |
|---|
| By CAS RN | C015329 |
|---|
| family name | count |
|---|---|
| Enterobacteriaceae | 3 |
| Rhodobacteraceae | 2 |
| Brassicaceae | 2 |
| Apiaceae | 1 |
| Rhizobiaceae | 1 |
| Nostocaceae | 1 |
| Solanaceae | 1 |
| Asteraceae | 1 |
| Rutaceae | 1 |
| Cucurbitaceae | 1 |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P02545 | Prelamin-A/C | Unclassified protein | CHEMBL501174 |
CHEMBL1614544
(1)
|
11 / 10 |
| P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL501174 |
CHEMBL1794311
(1)
|
2 / 3 |
| O75496 | Geminin | Unclassified protein | CHEMBL501174 |
CHEMBL2114843
(1)
CHEMBL2114780
(1)
|
0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL501174 |
CHEMBL1794467
(1)
|
0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL501174 |
CHEMBL1794536
(1)
|
0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL501174 |
CHEMBL1738442
(1)
|
0 / 0 |
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| C015329 | 118 |
ADD1
ADDA |
adducin 1 (alpha) | lycopene results in decreased expression of ADD1 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 177 |
AGER
RAGE |
advanced glycosylation end product-specific receptor | lycopene inhibits the reaction [HMGB1 protein results in increased expression of AGER protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 177 |
AGER
RAGE |
advanced glycosylation end product-specific receptor | lycopene inhibits the reaction [Lipopolysaccharides results in increased expression of AGER protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | lycopene results in decreased expression of AHR mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | lycopene results in decreased phosphorylation of AKT1 protein |
decreases phosphorylation
|
protein |
17337101
|
| C015329 | 367 |
AR
AIS DHTR HUMARA HYSP1 KD NR3C4 SBMA SMAX1 TFM |
androgen receptor | lycopene results in decreased expression of AR mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 571 |
BACH1
BACH-1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 | lycopene results in increased expression of BACH1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 8314 |
BAP1
HUCEP-13 UCHL2 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) | lycopene results in increased expression of BAP1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 673 |
BRAF
B-RAF1 BRAF1 NS7 RAFB1 |
v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) | lycopene results in decreased expression of BRAF protein |
decreases expression
|
protein |
17337101
|
| C015329 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | lycopene results in decreased expression of CASP8 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 847 |
CAT
|
catalase (EC:1.11.1.6) | lycopene results in increased expression of CAT |
increases expression
|
19450652
|
|
| C015329 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | lycopene inhibits the reaction [Genistein results in increased expression of CCND1 protein] |
decreases reaction
/ increases expression |
protein |
17051425
|
| C015329 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | lycopene inhibits the reaction [IGF1 protein results in increased expression of CCND1 protein] |
decreases reaction
/ increases expression |
protein |
16565789
|
| C015329 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | lycopene results in decreased expression of CCND1 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 898 |
CCNE1
CCNE |
cyclin E1 | lycopene results in decreased expression of CCNE1 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 898 |
CCNE1
CCNE |
cyclin E1 | lycopene results in increased expression of CCNE1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 983 |
CDK1
CDC2 CDC28A P34CDC2 |
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | lycopene results in decreased expression of CDK1 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 1019 |
CDK4
CMM3 PSK-J3 |
cyclin-dependent kinase 4 (EC:2.7.11.22) | lycopene results in decreased expression of CDK4 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 1020 |
CDK5
PSSALRE |
cyclin-dependent kinase 5 (EC:2.7.11.22) | lycopene results in decreased expression of CDK5 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 1022 |
CDK7
CAK1 CDKN7 HCAK MO15 STK1 p39MO15 |
cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) | lycopene results in decreased expression of CDK7 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 1025 |
CDK9
C-2k CDC2L4 CTK1 PITALRE TAK |
cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) | lycopene results in decreased expression of CDK9 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | lycopene inhibits the reaction [IGF1 protein results in increased expression of CDKN1A protein] |
decreases reaction
/ increases expression |
protein |
16565789
|
| C015329 | 1113 |
CHGA
CGA |
chromogranin A (parathyroid secretory protein 1) | lycopene results in increased expression of CHGA mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 1114 |
CHGB
SCG1 |
chromogranin B (secretogranin 1) | lycopene results in decreased expression of CHGB mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 23418 |
CRB1
LCA8 RP12 |
crumbs homolog 1 (Drosophila) | lycopene results in decreased expression of CRB1 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | lycopene results in increased activity of CYP3A4 protein |
increases activity
|
protein |
16632523
|
| C015329 | 1643 |
DDB2
DDBB UV-DDB2 |
damage-specific DNA binding protein 2, 48kDa | lycopene results in increased expression of DDB2 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 1981 |
EIF4G1
EIF-4G1 EIF4F EIF4G EIF4GI P220 PARK18 |
eukaryotic translation initiation factor 4 gamma, 1 | lycopene results in increased expression of EIF4G1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | lycopene inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
decreases reaction
/ increases activity |
protein |
17051425
|
| C015329 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | lycopene results in increased expression of ESR1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | lycopene inhibits the reaction [Estradiol results in increased activity of ESR2 protein] |
decreases reaction
/ increases activity |
protein |
17051425
|
| C015329 | 2176 |
FANCC
FA3 FAC FACC |
Fanconi anemia, complementation group C | lycopene results in decreased expression of FANCC mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 2188 |
FANCF
FAF |
Fanconi anemia, complementation group F | lycopene results in decreased expression of FANCF mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 356 |
FASLG
ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 |
Fas ligand (TNF superfamily, member 6) | lycopene results in decreased expression of FASLG mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | lycopene results in increased expression of FOS mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 2701 |
GJA4
CX37 |
gap junction protein, alpha 4, 37kDa | lycopene results in decreased expression of GJA4 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 2702 |
GJA5
ATFB11 CX40 |
gap junction protein, alpha 5, 40kDa | lycopene results in decreased expression of GJA5 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 2702 |
GJA5
ATFB11 CX40 |
gap junction protein, alpha 5, 40kDa | lycopene results in increased expression of GJA5 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 2879 |
GPX4
GPx-4 GSHPx-4 MCSP PHGPx snGPx snPHGPx |
glutathione peroxidase 4 (EC:1.11.1.12) | lycopene results in decreased expression of GPX4 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of AGER protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of PLA2G2A protein] |
decreases reaction
/ increases expression / increases secretion |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of TNF protein] |
decreases reaction
/ increases expression / increases secretion |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 mRNA] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE mRNA] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR2 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR4 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 mRNA] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene inhibits the reaction [Lipopolysaccharides results in increased secretion of HMGB1 protein] |
decreases reaction
/ increases secretion |
protein |
22429818
|
| C015329 | 3146 |
HMGB1
HMG1 HMG3 SBP-1 |
high mobility group box 1 | lycopene results in decreased susceptibility to HMGB1 protein |
decreases response to substance
|
protein |
22429818
|
| C015329 | 3383 |
ICAM1
BB2 CD54 P3.58 |
intercellular adhesion molecule 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22429818
|
| C015329 | 3383 |
ICAM1
BB2 CD54 P3.58 |
intercellular adhesion molecule 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of ICAM1 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | lycopene inhibits the reaction [IGF1 protein results in increased expression of CCND1 protein] |
decreases reaction
/ increases expression |
protein |
16565789
|
| C015329 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | lycopene inhibits the reaction [IGF1 protein results in increased expression of CDKN1A protein] |
decreases reaction
/ increases expression |
protein |
16565789
|
| C015329 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | lycopene inhibits the reaction [IGF1 protein results in increased phosphorylation of RB1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16565789
|
| C015329 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | lycopene results in decreased expression of IGF1 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | lycopene results in increased expression of IGF1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 3480 |
IGF1R
CD221 IGFIR IGFR JTK13 |
insulin-like growth factor 1 receptor (EC:2.7.10.1) | lycopene results in decreased expression of IGF1R protein |
decreases expression
|
protein |
17337101
|
| C015329 | 3485 |
IGFBP2
IBP2 IGF-BP53 |
insulin-like growth factor binding protein 2, 36kDa | lycopene results in increased expression of IGFBP2 protein |
increases expression
|
protein |
17337101
|
| C015329 | 3713 |
IVL
|
involucrin | lycopene results in decreased expression of IVL protein |
decreases expression
|
protein |
10769631
|
| C015329 | 3716 |
JAK1
JAK1A JAK1B JTK3 |
Janus kinase 1 (EC:2.7.10.2) | lycopene results in increased expression of JAK1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | lycopene results in decreased expression of JUN mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 3796 |
KIF2A
CDCBM3 HK2 KIF2 |
kinesin heavy chain member 2A | lycopene results in increased expression of KIF2A mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 3838 |
KPNA2
IPOA1 QIP2 RCH1 SRP1alpha |
karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | lycopene results in increased expression of KPNA2 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 3949 |
LDLR
FH FHC LDLCQ2 |
low density lipoprotein receptor | lycopene results in increased expression of LDLR mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 3988 |
LIPA
CESD LAL |
lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) | lycopene results in increased expression of LIPA mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 5604 |
MAP2K1
CFC3 MAPKK1 MEK1 MKK1 PRKMK1 |
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | lycopene results in increased expression of MAP2K1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 5605 |
MAP2K2
CFC4 MAPKK2 MEK2 MKK2 PRKMK2 |
mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) | lycopene results in decreased expression of MAP2K2 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 6416 |
MAP2K4
JNKK JNKK1 MAPKK4 MEK4 MKK4 PRKMK4 SAPKK-1 SAPKK1 SEK1 SERK1 SKK1 |
mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) | lycopene results in decreased expression of MAP2K4 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 5608 |
MAP2K6
MAPKK6 MEK6 MKK6 PRKMK6 SAPKK-3 SAPKK3 |
mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) | lycopene results in decreased expression of MAP2K6 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 1432 |
MAPK14
CSBP CSBP1 CSBP2 CSPB1 EXIP Mxi2 PRKM14 PRKM15 RK SAPK2A p38 p38ALPHA |
mitogen-activated protein kinase 14 (EC:2.7.11.24) | lycopene results in decreased expression of MAPK14 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 1432 |
MAPK14
CSBP CSBP1 CSBP2 CSPB1 EXIP Mxi2 PRKM14 PRKM15 RK SAPK2A p38 p38ALPHA |
mitogen-activated protein kinase 14 (EC:2.7.11.24) | lycopene results in increased expression of MAPK14 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | lycopene results in decreased expression of MAPK3 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | lycopene results in decreased expression of MAPK8 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 4247 |
MGAT2
CDG2A CDGS2 GLCNACTII GNT-II GNT2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) | lycopene results in increased expression of MGAT2 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 100507436 |
MICA
MIC-A PERB11.1 |
MHC class I polypeptide-related sequence A | lycopene results in increased expression of MICA mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 4292 |
MLH1
COCA2 FCC2 HNPCC HNPCC2 hMLH1 |
mutL homolog 1 | lycopene results in increased expression of MLH1 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 4436 |
MSH2
COCA1 FCC1 HNPCC HNPCC1 LCFS2 |
mutS homolog 2 | lycopene results in increased expression of MSH2 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 2956 |
MSH6
GTBP GTMBP HNPCC5 HSAP p160 |
mutS homolog 6 | lycopene results in increased expression of MSH6 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 4842 |
NOS1
IHPS1 N-NOS NC-NOS NOS bNOS nNOS |
nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) | lycopene results in decreased expression of NOS1 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 8021 |
NUP214
CAIN CAN D9S46E N214 p250 |
nucleoporin 214kDa | lycopene results in decreased expression of NUP214 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 5320 |
PLA2G2A
MOM1 PLA2 PLA2B PLA2L PLA2S PLAS1 sPLA2 |
phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) | lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of PLA2G2A protein] |
decreases reaction
/ increases expression / increases secretion |
protein |
22429818
|
| C015329 | 5591 |
PRKDC
DNA-PKcs DNAPK DNPK1 HYRC HYRC1 XRCC7 p350 |
protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) | lycopene results in decreased expression of PRKDC mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 10111 |
RAD50
NBSLD RAD502 hRad50 |
RAD50 homolog (S. cerevisiae) | lycopene results in increased expression of RAD50 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 8045 |
RASSF7
C11orf13 HRAS1 HRC1 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 | lycopene results in increased expression of RASSF7 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 5925 |
RB1
OSRC RB p105-Rb pRb pp110 |
retinoblastoma 1 | lycopene inhibits the reaction [Genistein results in increased phosphorylation of and results in decreased activity of RB1 protein] |
decreases activity
/ decreases reaction / increases phosphorylation |
protein |
17051425
|
| C015329 | 5925 |
RB1
OSRC RB p105-Rb pRb pp110 |
retinoblastoma 1 | lycopene inhibits the reaction [IGF1 protein results in increased phosphorylation of RB1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16565789
|
| C015329 | 5925 |
RB1
OSRC RB p105-Rb pRb pp110 |
retinoblastoma 1 | lycopene results in decreased phosphorylation of RB1 protein |
decreases phosphorylation
|
protein |
17337101
|
| C015329 | 5962 |
RDX
DFNB24 |
radixin | lycopene results in decreased expression of RDX mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 6195 |
RPS6KA1
HU-1 MAPKAPK1A RSK RSK1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) | lycopene results in decreased expression of RPS6KA1 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 6197 |
RPS6KA3
CLS HU-3 ISPK-1 MAPKAPK1B MRX19 RSK RSK2 S6K-alpha3 p90-RSK2 pp90RSK2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) | lycopene results in decreased expression of RPS6KA3 protein |
decreases expression
|
protein |
17337101
|
| C015329 | 6241 |
RRM2
R2 RR2 RR2M |
ribonucleotide reductase M2 (EC:1.17.4.1) | lycopene results in increased expression of RRM2 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 6401 |
SELE
CD62E ELAM ELAM1 ESEL LECAM2 |
selectin E | lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE mRNA] |
decreases reaction
/ increases expression |
mRNA |
22429818
|
| C015329 | 6401 |
SELE
CD62E ELAM ELAM1 ESEL LECAM2 |
selectin E | lycopene inhibits the reaction [HMGB1 protein results in increased expression of SELE protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 6414 |
SEPP1
SELP SeP |
selenoprotein P, plasma, 1 | lycopene results in decreased expression of SEPP1 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 4088 |
SMAD3
HSPC193 HsT17436 JV15-2 LDS1C LDS3 MADH3 |
SMAD family member 3 | lycopene results in increased expression of SMAD3 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 8243 |
SMC1A
CDLS2 DXS423E SB1.8 SMC1 SMC1L1 SMC1alpha SMCB |
structural maintenance of chromosomes 1A | lycopene results in decreased expression of SMC1A mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 6774 |
STAT3
APRF HIES |
signal transducer and activator of transcription 3 (acute-phase response factor) | lycopene results in increased expression of STAT3 mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 7031 |
TFF1
BCEI D21S21 HP1.A HPS2 pNR-2 pS2 |
trefoil factor 1 | lycopene results in decreased expression of TFF1 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 7980 |
TFPI2
PP5 REF1 TFPI-2 |
tissue factor pathway inhibitor 2 | lycopene results in decreased expression of TFPI2 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 7039 |
TGFA
TFGA |
transforming growth factor, alpha | lycopene results in increased expression of TGFA mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 7097 |
TLR2
CD282 TIL4 |
toll-like receptor 2 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR2 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 7097 |
TLR2
CD282 TIL4 |
toll-like receptor 2 | lycopene inhibits the reaction [Lipopolysaccharides results in increased expression of TLR2 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 7099 |
TLR4
ARMD10 CD284 TLR-4 TOLL |
toll-like receptor 4 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of TLR4 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 7099 |
TLR4
ARMD10 CD284 TLR-4 TOLL |
toll-like receptor 4 | lycopene inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of TNF protein] |
decreases reaction
/ increases expression / increases secretion |
protein |
22429818
|
| C015329 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | lycopene results in decreased expression of TP53 mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22429818
|
| C015329 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | lycopene inhibits the reaction [HMGB1 protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
22429818
|
| C015329 | 7415 |
VCP
ALS14 IBMPFD IBMPFD1 TERA p97 |
valosin containing protein (EC:3.6.4.6) | lycopene results in increased expression of VCP mRNA |
increases expression
|
mRNA |
16886892
|
| C015329 | 7485 |
WRB
CHD5 |
tryptophan rich basic protein | lycopene results in decreased expression of WRB mRNA |
decreases expression
|
mRNA |
16886892
|
| C015329 | 7697 |
ZNF138
pHZ-32 |
zinc finger protein 138 | lycopene results in increased expression of ZNF138 mRNA |
increases expression
|
mRNA |
16886892
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D056486 | C015329 | Drug-Induced Liver Injury |
therapeutic
|
22192907
|
|
| D006943 | C015329 | Hyperglycemia |
therapeutic
|
22192907
|
|
| D006965 | C015329 | Hyperplasia |
therapeutic
|
19329757
|
|
| D007248 | C015329 | Infertility, Male |
therapeutic
|
19071209
20074268 |
|
| D007249 | C015329 | Inflammation |
therapeutic
|
22429818
|
|
| D007674 | C015329 | Kidney Diseases |
therapeutic
|
22108423
|
|
| D009369 | C015329 | Neoplasms |
therapeutic
|
17051425
22429818 |
|
| D020258 | C015329 | Neurotoxicity Syndromes |
therapeutic
|
22192907
|
|
| D011471 | C015329 | Prostatic Neoplasms |
therapeutic
|
15084515
17337101 |
|
| D012878 | C015329 | Skin Neoplasms |
therapeutic
|
19329757
|
|
| D013733 | C015329 | Testicular Diseases |
therapeutic
|
20074268
|
|
| D014178 | C015329 | Translocation, Genetic |
therapeutic
|
19450652
|
|
| D015431 | C015329 | Weight Loss |
therapeutic
|
17873360
|